Literature DB >> 10340189

Benzodiazepine use among the elderly in the community.

M Kirby1, A Denihan, I Bruce, A Radic, D Coakley, B A Lawlor.   

Abstract

Benzodiazepines are the most commonly prescribed psychotropic drug in the elderly. Benzodiazepines with a long duration of action can produce marked sedation and psychomotor impairment in older people, and are associated with an increased risk of hip fracture and of motor vehicle crash. One thousand seven hundred and one individuals of 65 years and over, identified from General Practitioner lists, were interviewed using the Geriatric Mental State-AGECAT package and current psychotropic drug use was recorded. Benzodiazepines were classified as having a short or long elimination half-life. Two hundred and ninety-five (17.3%) individuals were taking a benzodiazepine, with use in females being twice that in males. Of the 295, 152 (51.5%) were taking a long acting benzodiazepine and the use of long acting anxiolytic type benzodiazepines was particularly common. Fifty-two (17.6%) benzodiazepine users were taking one or more other psychotropic drugs. A benzodiazepine was used by eight of 18 (44.4%) subjects with an anxiety disorder, 62 of 180 (34.4%) individuals with depression, and seven of 71 (9.9%) people with dementia. Four-fifths of older people on a psychotropic drug were taking a benzodiazepine, highlighting the importance of this class of drug in the elderly population. The choice of a benzodiazepine with a long duration of action, which have been shown to be associated with serious adverse events in the elderly in over one half of benzodiazepine users, is of concern. The potential for adverse effects was further accentuated by polypharmacy practices. The choice of benzodiazepine for an older person has important consequences and should be addressed in greater detail with primary care.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340189

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  15 in total

1.  Inappropriate drug use by Portuguese elderly outpatients--effect of the Beers criteria update.

Authors:  Sofia de Oliveira Martins; Maria Augusta Soares; J W Foppe van Mil; José Cabrita
Journal:  Pharm World Sci       Date:  2006-11-17

2.  Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.

Authors:  Olivia Boeuf-Cazou; Bienvenu Bongue; David Ansiau; Jean-Claude Marquié; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2011-04-15       Impact factor: 2.953

3.  Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Authors:  Nicholas T Vozoris; Zhan Yao; Ping Li; Peter C Austin; Anne L Stephenson; Sudeep S Gill; Denis E O'Donnell; Andrea S Gershon; Paula A Rochon
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

4.  Benzodiazepines and hip fractures in elderly people: case-control study.

Authors:  C Pierfitte; G Macouillard; M Thicoïpe; A Chaslerie; F Pehourcq; M Aïssou; B Martinez; R Lagnaoui; A Fourrier; B Bégaud; J Dangoumau; N Moore
Journal:  BMJ       Date:  2001-03-24

5.  Consumption of pharmaceuticals in primary non-Alzheimer's degenerative dementias : a cross-sectional study by the Registry of Dementias of Girona (ReDeGi).

Authors:  Secundino López-Pousa; Oriol Turró-Garriga; Laia Calvó-Perxas; Olga Carmona; Jordi Gich; Elisabet Alsina; Fabià Màrquez; Marta Viñas; Josefa Turbau; Joan Vilalta-Franch; Anna Maria Roig; Josep Garre-Olmo
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

6.  Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Geoffrey M Anderson; Chaim M Bell; Andrea S Gershon; Anne L Stephenson; Sudeep S Gill; Paula A Rochon
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

Review 7.  Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.

Authors:  Deborah A Burton; Grainne Nicholson; George M Hall
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 8.  Benzodiazepines and risk of hip fractures in older people: a review of the evidence.

Authors:  Robert G Cumming; David G Le Couteur
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a Taiwanese medical setting.

Authors:  Hsi-Yen Lin; Chi-Chow Liao; Shou-Hsia Cheng; Pa-Chun Wang; Ya-Seng Hsueh
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons.

Authors:  Gillian Bartlett; Michal Abrahamowicz; Roland Grad; Marie-Pierre Sylvestre; Robyn Tamblyn
Journal:  BMC Fam Pract       Date:  2009-01-06       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.